INVEX THERAPEUTICS LTD - Corporate Spotlight

Market Cap $6.012M Add to my watchlist

Healthcare

Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical... Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure. Our primary focus is on the orphan disease Idiopathic Intracranial Hypertension (IIH), a large and growing market opportunity with no regulatory cleared treatmentsMore

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

No Corporate Spotlight currently available.

(20min delay)
Last 8.0¢		Change -0.002(2.44%)		Mkt cap ! $6.012M

Open	High	Low	Value	Volume
8.2¢	8.2¢	8.0¢	$572	6.987K

Buyers (Bids)

No.	Vol.	Price($)
1	28219	8.0¢

Sellers (Offers)

Price($)	Vol.	No.
8.6¢	2202	1

View Market Depth

No.	Vol.	Price($)
1	28219	0.080
1	100000	0.070
1	32000	0.060
2	60001	0.047
2	100001	0.038

Price($)	Vol.	No.
0.086	2202	1
0.090	126146	1
0.095	100000	1
0.100	76646	2
0.110	100000	1

Last trade - 15.34pm 02/05/2024 (20 minute delay)

IXC (ASX) Chart

INVEX THERAPEUTICS LTD - Corporate Spotlight

Corporate SpotlightNot Yet Available

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available